YAP1 and neoplasm: The transcriptional co‐activators YAP and TAZ have been identified as central mediators of metastatic progression, driving critical processes such as epithelial‐to‐mesenchymal transition (EMT), tumour cell invasion and adaptation to the metastatic microenvironment [33, 34, 35].